Literature DB >> 25043729

Deletion of forebrain glycine transporter 1 enhances conditioned freezing to a reliable, but not an ambiguous, cue for threat in a conditioned freezing paradigm.

Sylvain Dubroqua1, Philipp Singer1, Benjamin K Yee2.   

Abstract

Enhanced expression of Pavlovian aversive conditioning but not appetitive conditioning may indicate a bias in the processing of threatening or fearful events. Mice with disruption of glycine transporter 1 (GlyT1) in forebrain neurons exhibit such a bias, but they are at the same time highly sensitive to manipulations that hinder the development of the conditioned response (CR) suggesting that the mutation may modify higher cognitive processes that extract predictive information between environmental cues. Here, we further investigated the development of fear conditioning in forebrain neuronal GlyT1 knockout mice when the predictiveness of a tone stimulus for foot-shock was rendered ambiguous by interspersing [tone→no shock] trials in-between [tone→shock] trials during acquisition. The CR to the ambiguous tone CS (conditioned stimulus) was compared with that generated by an unambiguous CS that was always followed by the shock US (unconditioned stimulus) during acquisition. We showed that rendering the CS ambiguous as described significantly attenuated the CR in the mutants, but it was not sufficient to modify the CR in the control mice. It is concluded that disruption of GlyT1 in forebrain neurons does not increase the risk of forming spurious and potentially maladaptive fear associations.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fear; Glutamate; Glycine reuptake; Learning; NMDA receptor; Pavlovian conditioning

Mesh:

Substances:

Year:  2014        PMID: 25043729      PMCID: PMC4435955          DOI: 10.1016/j.bbr.2014.07.018

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  29 in total

1.  Glycine transporter inhibition reverses ketamine-induced working memory deficits.

Authors:  Brooke M Roberts; Christopher L Shaffer; Patricia A Seymour; Christopher J Schmidt; Graham V Williams; Stacy A Castner
Journal:  Neuroreport       Date:  2010-03-31       Impact factor: 1.837

2.  Forebrain glycine transporter 1 deletion enhances sensitivity to CS-US discontiguity in classical conditioning.

Authors:  Philipp Singer; Sylvain Dubroqua; Benjamin K Yee
Journal:  Neurobiol Learn Mem       Date:  2014-01-27       Impact factor: 2.877

3.  Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes.

Authors:  N W Kleckner; R Dingledine
Journal:  Science       Date:  1988-08-12       Impact factor: 47.728

4.  Glycine transporter 1 as a potential therapeutic target for schizophrenia-related symptoms: evidence from genetically modified mouse models and pharmacological inhibition.

Authors:  Hanns Möhler; Detlev Boison; Philipp Singer; Joram Feldon; Meike Pauly-Evers; Benjamin K Yee
Journal:  Biochem Pharmacol       Date:  2011-02-17       Impact factor: 5.858

5.  Examining the sex- and circadian dependency of a learning phenotype in mice with glycine transporter 1 deletion in two Pavlovian conditioning paradigms.

Authors:  Sylvain Dubroqua; Detlev Boison; Joram Feldon; Hanns Möhler; Benjamin K Yee
Journal:  Neurobiol Learn Mem       Date:  2011-05-10       Impact factor: 2.877

6.  Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5.

Authors:  R G Morris; E Anderson; G S Lynch; M Baudry
Journal:  Nature       Date:  1986 Feb 27-Mar 5       Impact factor: 49.962

7.  The glycine transporter-1 inhibitor SSR103800 displays a selective and specific antipsychotic-like profile in normal and transgenic mice.

Authors:  Denis Boulay; Olivier Bergis; Patrick Avenet; Guy Griebel
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

8.  Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels.

Authors:  Marzia Martina; Yelena Gorfinkel; Samantha Halman; John A Lowe; Pranav Periyalwar; Christopher J Schmidt; Richard Bergeron
Journal:  J Physiol       Date:  2004-04-02       Impact factor: 5.182

9.  Altered mnemonic functions and resistance to N-METHYL-d-Aspartate receptor antagonism by forebrain conditional knockout of glycine transporter 1.

Authors:  P Singer; B K Yee; J Feldon; T Iwasato; S Itohara; T Grampp; G Prenosil; D Benke; H Möhler; D Boison
Journal:  Neuroscience       Date:  2009-03-28       Impact factor: 3.590

Review 10.  Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain.

Authors:  Robert J Harvey; Benjamin K Yee
Journal:  Nat Rev Drug Discov       Date:  2013-11       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.